Skip to main navigation Skip to search Skip to main content

Wound healing adverse events in kidney transplant recipients receiving everolimus with reduced calcineurin inhibitor exposure or current standard-of-care: Insights from the 24 month TRANSFORM study

  • Franco Citterio*
  • , Mitchell Henry
  • , Dean Y. Kim
  • , Myoung Soo Kim
  • , Duck Jong Han
  • , Takashi Kenmochi
  • , Eytan Mor
  • , Giuseppe Tisone
  • , Peter Bernhardt
  • , Maria Pilar Hernandez Gutierrez
  • , Yoshihiko Watarai
  • *Corresponding author for this work
  • Catholic University of Sacred Heart
  • Ohio State University
  • Henry Ford Health System
  • Yonsei University
  • University of Ulsan
  • Fujita Health University
  • Sheba Medical Center at Tel Hashomer
  • University of Rome Tor Vergata
  • Novartis
  • Japanese Red Cross Nagoya Daini Hospital

Research output: Contribution to journalArticlepeer-review

7 Scopus citations

Fingerprint

Dive into the research topics of 'Wound healing adverse events in kidney transplant recipients receiving everolimus with reduced calcineurin inhibitor exposure or current standard-of-care: Insights from the 24 month TRANSFORM study'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science